Mutations in CHEK2 Associated with Prostate Cancer Risk

The DNA-damage–signaling pathway has been implicated in all human cancers. However, the genetic defects and the mechanisms of this pathway in prostate carcinogenesis remain poorly understood. In this study, we analyzed CHEK2, the upstream regulator of p53 in the DNA-damage–signaling pathway, in seve...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Dong, Xiangyang, Wang, Liang, Taniguchi, Ken, Wang, Xianshu, Cunningham, Julie M., McDonnell, Shannon K., Qian, Chiping, Marks, Angela F., Slager, Susan L., Peterson, Brett J., Smith, David I., Cheville, John C., Blute, Michael L., Jacobsen, Steve J., Schaid, Daniel J., Tindall, Donald J., Thibodeau, Stephen N., Liu, Wanguo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: The American Society of Human Genetics 2003
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC379222/
https://ncbi.nlm.nih.gov/pubmed/12533788
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller